US 7,371,889 B2
	Chemical entities with multiple modes of anti-inflammatory action
Muhammed Majeed, Piscataway, N.J. (US); Kalyanam Nagebhuananam, Piscataway, N.J. (US); Rajendran Ramanujam, Bangalore (India); and Subbalakshmi Prakash, Piscataway, N.J. (US)
Assigned to Sami Labs Limited, Bangalore (India)
Filed on Mar. 11, 2007, as Appl. No. 11/684,631.
Application 11/684631 is a continuation in part of application No. 10/248477, filed on Jan. 22, 2003, abandoned.
Claims priority of provisional application 60/364054, filed on Mar. 15, 2002.
Prior Publication US 2007/0155709 A1, Jul. 05, 2007
Int. Cl. C07C 69/753 (2006.01); C07C 69/75 (2006.01); C07C 67/74 (2006.01)

U.S. Cl. 560—126  [560/127; 560/128; 560/5; 560/55; 562/510; 562/498; 514/825; 514/886; 514/925; 514/33; 514/559; 514/547; 424/195.1]

2 Claims

1. Chemical compounds wherein 3-acetyl-11-keto-β-boswellic acid is linked by a methylene bridge with a chemical entity selected from Ibuprofen, Naproxen, Ketoprofen, Acetylsalicylic acid, Indomethacin, Carprofen, Fenbufen, Fenoprofen, Flurbiprofen, Loxoprofen, Tiaprofenic acid, Suprofen, Diclofenac, Piroxicam, Phenylbutazone, Nimesulide.